Christian Jansen Selected Research

Transjugular Intrahepatic Portasystemic Shunt

6/2022	Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study.
5/2022	TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension.
3/2022	Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
1/2022	Cranial stent position is independently associated with the development of TIPS dysfunction.
8/2021	Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study.
7/2021	Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure.
6/2021	Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
1/2021	Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
1/2021	Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt.
1/2021	Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Jansen Research Topics

Disease

33	Fibrosis (Cirrhosis) 03/2022 - 01/2014
19	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2014
17	Portal Hypertension 06/2022 - 01/2014
13	Ascites 06/2022 - 01/2014
10	Hemorrhage 06/2022 - 02/2015
10	Acute-On-Chronic Liver Failure 03/2022 - 01/2018
10	Inflammation (Inflammations) 04/2021 - 02/2015
9	End Stage Liver Disease 03/2022 - 01/2020
9	Hepatic Encephalopathy 01/2022 - 01/2018
8	Liver Diseases (Liver Disease) 04/2021 - 02/2015
4	Bacterial Infections (Bacterial Infection) 04/2021 - 01/2020
3	Varicose Veins (Varicose Vein) 05/2022 - 01/2020
3	Sarcopenia 01/2022 - 01/2018
2	Infections 01/2021 - 01/2020
1	Heart Failure 06/2021
1	Disease Progression 04/2021
1	Brain Diseases (Brain Disorder) 04/2021
1	Liver Failure 04/2021
1	Hypoalbuminemia 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Edema (Dropsy) 10/2020
1	Peritonitis 01/2020
1	Cross Infection (Nosocomial Infection) 01/2020
1	Necrosis 01/2020
1	Cholangiocarcinoma 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Thrombosis (Thrombus) 05/2016
1	Neoplasms (Cancer) 05/2016
1	Leukemia 05/2016
1	HIV Infections (HIV Infection) 01/2015
1	Coinfection 01/2014
1	Atherosclerosis 01/2005

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
4	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2015
3	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2015
3	AlbuminsIBA 01/2021 - 01/2020
2	theasinensin AIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	InflammasomesIBA 01/2021 - 01/2021
2	LigandsIBA 01/2020 - 01/2018
2	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2020 - 01/2017
2	CollagenIBA 01/2019 - 02/2015
2	Complement C3 (C3 Complement)IBA 01/2019 - 01/2014
2	ChemokinesIBA 03/2016 - 02/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015 - 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2022
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	NitrogenIBA 12/2021
1	CytokinesIBA 04/2021
1	Macrophage Migration-Inhibitory FactorsIBA 04/2021
1	C-Reactive ProteinIBA 04/2021
1	angiogeninIBA 01/2021
1	EnzymesIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2021
1	BilirubinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	GadoliniumIBA 10/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	SodiumIBA 01/2020
1	Integrin-Binding SialoproteinIBA 01/2020
1	OsteopontinIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	CC ChemokinesIBA 01/2020
1	Angiotensin-Converting Enzyme 2IBA 03/2019
1	Gemcitabine FDA Link 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	Thromboxane B2IBA 01/2019
1	ProstaglandinsIBA 01/2019
1	MetalsIBA 01/2019
1	Prostaglandin D2IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	fibroblast growth factor 21IBA 01/2018
1	InterleukinsIBA 01/2018
1	Superoxide DismutaseIBA 07/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	TransferasesIBA 05/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2005

Therapy/Procedure

24	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2022 - 02/2015
22	Transjugular Intrahepatic Portasystemic Shunt 06/2022 - 01/2014
6	Liver Transplantation 01/2022 - 01/2018
4	Therapeutics 05/2022 - 01/2014
4	Stents 06/2021 - 01/2017
2	Ligation 01/2021 - 01/2021
1	Operative Surgical Procedures 07/2021
1	Patient Readmission 06/2021
1	Antibiotic Prophylaxis 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Artificial Liver (Bioartificial Liver) 01/2018